STAT3-Interacting Proteins as Modulators of Transcription Factor Function: Implications to Targeted Cancer Therapy

Jennifer E Yeh1, David A Frank2

  • 1Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA, 02215, USA.

Chemmedchem
|December 15, 2015
PubMed

Insights

Signal transducer and activator of transcription 3 (STAT3) is a key oncogenic factor in many cancers. This study explores STAT3-interacting proteins, identifying novel targets to inhibit its cancer-promoting functions.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Signal transducer and activator of transcription 3 (STAT3) is a transcription factor crucial for cell processes.
  • Aberrant STAT3 activation is implicated in numerous cancers, driving proliferation, survival, and angiogenesis.
  • Current inhibition strategies target STAT3 kinases or DNA binding, overlooking protein interactions.

Purpose of the Study:

  • To review known STAT3-interacting proteins.
  • To highlight the potential of proteomics for discovering novel STAT3 interactors.
  • To characterize how these interactions modulate STAT3's oncogenic activity.

Main Methods:

  • Literature review of STAT3-interacting proteins.
  • Description of proteomics-based approaches for identifying protein interactions.
  • Characterization of identified proteins' effects on STAT3 activity.

Main Results:

  • STAT3 protein interactions modulate its oncogenic functions.
  • Proteomics successfully identifies novel STAT3-interacting proteins.
  • These interactions influence STAT3's localization, DNA binding, and transcriptional activity.

Conclusions:

  • STAT3 protein interactions represent a promising therapeutic target.
  • Proteomics offers a powerful tool for uncovering these interactions.
  • Targeting STAT3-protein complexes could offer new cancer treatment strategies.

Related Concept Videos

Co-activators and Co-repressors02:04

Co-activators and Co-repressors

Gene transcription is regulated by the synergistic action of several proteins that form a complex at a gene regulatory site. This is observed in eukaryotes, where the regulation of gene expression is a complex process. Regulatory proteins in eukaryotes can broadly be classified into two types – regulators that bind directly to specific DNA sequences and co-regulators that associate with regulatory proteins but cannot directly bind to the DNA. These co-regulators are further divided into...
8.9K
Co-activators and Co-repressors02:04

Co-activators and Co-repressors

3.2K
Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
8.0K
RNA Polymerase II Accessory Proteins02:36

RNA Polymerase II Accessory Proteins

Proteins that regulate transcription can do so either via direct contact with RNA Polymerase or through indirect interactions facilitated by adaptors, mediators, histone-modifying proteins, and nucleosome remodelers. Direct interactions to activate transcription is seen in bacteria as well as in some eukaryotic genes. In these cases, upstream activation sequences are adjacent to the promoters, and the activator proteins interact directly with the transcriptional machinery. For example, in...
11.4K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

1.7K